Healthcare


Global Interventional X-Ray Market, Forecast to 2021

The study aims to analyze and forecast the Interventional X-ray market in the United States, Europe, and select Asia-Pacific countries for 2016. Research Scope: Market trends (utilization of conventional and emerging clinical applications, growth indicators, factors influencing ROI, critical unmet needs and potential game changing strategies, growth opportunities for fixed interventional X-ray and surgical C-arm systems, emerging clinical application trends, technology trends driving IXR growth, and future prospects); company profiles; competitive structure; market metrics; market share; revenues; and strategies. Regional Scope: • United States • Europe: Western Europe (Germany, United Kingdom, Italy, France, Spain, Benelux, Scandinavia) and Eastern Europe (Poland, Czech Republic, Hungary, Bulgaria, Romania) • Asia-Pacific (Australia, India, Japan, Thailand, Indonesia, Malaysia) Market Segmentation: Fixed interventional X-ray sub-segment (single plane, bi-plane) and Surgical C-arm (Mobile and Mini C-arm), and by the three regions. Market measurements are analyzed for the year 2014-2016 and forecasted up to 202. Revenue and year-on-year growth rates are provided by regions and market segments. Pricing range and growth trends by sub-segment for the base year are discussed. Furthermore, an extensive list of the must-watch manufacturers in the interventional X-ray space in 2016 is provided. Interventional X-ray (IXR) has become ubiquitous in most secondary and tertiary care hospitals as a standard interventional and diagnostic tool for radiology and cardiology. Despite IXR being a matured segment, technological innovation in recent years has resulted in multi-modality integration that blends various clinical applications, which can be carried out using a single suite. With the advent of private hospitals and favorable reimbursements of health insurance, there is more demand for patient safety and high quality technologies, reduced hospitalization, and reduction in overall healthcare costs. Globally, countries are emphasizing safety and outcomes caused by X-ray systems, reduced radiation, seamless workflow, and cost-competitiveness. These factors determine the growth of the interventional X-ray market. Strategies, growth analysis, competitive landscape, and future focus are discussed for vendors (GE Healthcare, Philips Healthcare, Siemens Healthcare, EMD Medical Technologies, Technix, Stephanix S.A, Hologic Inc., Medtronic, BMI Biomedical International s.r.l., EcoRay, Eurocolumbus s.r.l., Intermedical S.r.l., Shimadzu Corporation, Simad S.r.l., and Ziehm Imaging GMBH). The base year for the study is 2016, historic years (2014 and 2015) with 2017 to 2021 as the forecast period.
Published: 8 Aug 2017

Global Interventional X-Ray Market, Forecast to 2021

Growth Opportunities in Image Guidance will Drive Interventional X-rays (IXR) in the Billion-dollar Imaging Market

The study aims to analyze and forecast the Interventional X-ray market in the United States, Europe, and select Asia-Pacific countries for 2016.

Research Scope:
Market trends (utilization of conventional and emerging clinical applications, growth indicators, factors influencing ROI, critical unmet needs and potential game changing strategies, growth opportunities for fixed interventional X-ray and surgical C-arm systems, emerging clinical application trends, technology trends driving IXR growth, and future prospects); company profiles; competitive structure; market metrics; market share; revenues; and strategies.

Regional Scope:

  • United States
  • Europe: Western Europe (Germany, United Kingdom, Italy, France, Spain, Benelux, Scandinavia) and Eastern Europe (Poland, Czech Republic, Hungary, Bulgaria, Romania)
  • Asia-Pacific (Australia, India, Japan, Thailand, Indonesia, Malaysia)

Market Segmentation:
Fixed interventional X-ray sub-segment (single plane, bi-plane) and Surgical C-arm (Mobile and Mini C-arm), and by the three regions.

Market measurements are analyzed for the year 2014-2016 and forecasted up to 202. Revenue and year-on-year growth rates are provided by regions and market segments. Pricing range and growth trends by sub-segment for the base year are discussed. Furthermore, an extensive list of the must-watch manufacturers in the interventional X-ray space in 2016 is provided.

Interventional X-ray (IXR) has become ubiquitous in most secondary and tertiary care hospitals as a standard interventional and diagnostic tool for radiology and cardiology. Despite IXR being a matured segment, technological innovation in recent years has resulted in multi-modality integration that blends various clinical applications, which can be carried out using a single suite. With the advent of private hospitals and favorable reimbursements of health insurance, there is more demand for patient safety and high quality technologies, reduced hospitalization, and reduction in overall healthcare costs.

Globally, countries are emphasizing safety and outcomes caused by X-ray systems, reduced radiation, seamless workflow, and cost-competitiveness. These factors determine the growth of the interventional X-ray market.

Strategies, growth analysis, competitive landscape, and future focus are discussed for vendors (GE Healthcare, Philips Healthcare, Siemens Healthcare, EMD Medical Technologies, Technix, Stephanix S.A, Hologic Inc., Medtronic, BMI Biomedical International s.r.l., EcoRay, Eurocolumbus s.r.l., Intermedical S.r.l., Shimadzu Corporation, Simad S.r.l., and Ziehm Imaging GMBH).

The base year for the study is 2016, historic years (2014 and 2015) with 2017 to 2021 as the forecast period.

Key Questions this Study will Answer:

  • Is the global interventional X-ray market growing? How long will it continue to grow and at what rate? What is the future potential of the market?
  • Which growth segments of the market are most likely to accelerate the recovery of market size (historic) and growth rates, and over which period of time?
  • What are the key market drivers and restraints impacting growth opportunities in the global interventional X-ray market?
  • What is the regional landscape for interventional X-rays in Europe and Asia-Pacific? How do government spending, healthcare regulations, and policies affect the market?
  • What are the main current and future developments in clinical guidelines? How are they expected to play a role either in favor or to the detriment of interventional X-ray equipment adoption?
  • What is the outlook on current industry dynamics? Is the concentration around the top three market participants likely to increase, or is the market more likely to diversify?

Features of this Research

Help Desk

Full list of offices


For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..